Search clinical trials for: Durvalumab, etoposide, and cisplatin/carboplatin followed by durvalumab and olaparib
Total 427 results
-
BeiGeneActive, not recruiting
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingSmall Cell Lung Cancer Extensive StageFrance
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT); Myriad... and other collaboratorsActive, not recruitingAdvanced Ovarian CancerCanada, Denmark, Germany, Italy, Spain, United States, Belgium, Poland, France, Korea, Republic of, Brazil, Hungary, Japan, Peru, Turkey, China, Austria, Bulgaria, Finland, Romania
-
Centre Leon BerardCompletedFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)Squamous Cell Carcinoma of the Head and NeckFrance
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma (SCLC)Spain, Belgium, Japan, France, Poland, Germany
-
Hellenic Cooperative Oncology GroupAstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGreece
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingOropharyngeal Squamous Cell CarcinomaCanada, Spain, Belgium, Italy
-
Shanghai Henlius BiotechRecruitingLimited-Stage Small Cell Lung CancerUnited States, China, Greece, Spain, Austria, Czechia, Germany, Hungary, Latvia, Netherlands, Poland
-
University of Alabama at BirminghamCompletedCholangiocarcinomaUnited States
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Masonic Cancer Center, University of MinnesotaRecruitingLung Cancer | Adenocarcinoma of LungUnited States
-
AstraZenecaApproved for marketing
-
SanofiCompletedLung NeoplasmsFrance, Netherlands, Spain, Turkey, Belgium, Finland, Italy, United Kingdom
-
AstraZenecaCompletedMelanoma | Breast Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Gastroesophageal CancerUnited States
-
Peking Union Medical College HospitalAstraZenecaRecruitingNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCRecruitingCarcinoma, Non-Small-Cell LungUnited States, Australia, Brazil, Chile, China, Costa Rica, Dominican Republic, Germany, Greece, Guatemala, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Spain, Turkey, Portugal, Romania, South Africa
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRTChina
-
Samsung Medical CenterUnknownSmall Cell Lung CancerKorea, Republic of
-
ARCAGY/ GINECO GROUPActive, not recruitingEpithelial Ovarian Cancer | RelapseFrance
-
Wake Forest University Health SciencesAstraZeneca; Atrium Health Levine Cancer InstituteActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage III | Lung Cancer Stage IIUnited States
-
AstraZenecaActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingEsophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Taiwan, Korea, Republic of, Japan, Spain
-
Peking UniversityRecruitingNeuroendocrine Carcinoma of the BladderChina
-
PfizerTerminatedSmall Cell Lung CarcinomaUnited States, Spain, Canada, Hungary
-
Guangdong Association of Clinical TrialsGuangdong Provincial People's HospitalRecruitingSmall-cell Lung CancerChina
-
Insel Gruppe AG, University Hospital BernSwiss Cancer LeagueNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterTerminated
-
University of BirminghamAstraZeneca; Cancer Trials IrelandRecruitingOropharyngeal CancerUnited Kingdom, Ireland
-
Samsung Medical CenterUnknownEsophageal Squamous Cell CarcinomaKorea, Republic of
-
Asan Medical CenterRecruitingBiliary Tract Cancer | DNA Damage Repair DeficiencyKorea, Republic of
-
University Hospital MuensterHannover Medical School; Deutsche Kinderkrebsstiftung; Gesellschaft fur Padiatrische...UnknownIntracranial Germ Cell TumorsGermany
-
Taizhou HospitalNot yet recruitingSmall Cell Lung CarcinomaChina
-
Beijing Tiantan HospitalRecruitingIntracranial Germ Cell CNS Tumor, ChildhoodChina
-
Peking Union Medical College HospitalHarbin Medical University; The First Affiliated Hospital of Xiamen UniversityRecruitingNeuroendocrine Tumors | Neuroendocrine CarcinomaChina
-
European Organisation for Research and Treatment...WithdrawnSquamous Cell Head and Neck Carcinoma
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom
-
Latin American Cooperative Oncology GroupTerminated
-
Lee's Pharmaceutical LimitedRecruitingExtensive Stage Small Cell Lung CancerChina
-
Peking Union Medical College HospitalCompletedEsophageal Squamous Cell CarcinomaChina
-
National Cancer Institute (NCI)RecruitingEGFR-Mutated Non-Small-Cell Lung Carcinoma | Small Cell/NeuroendocrineUnited States
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; Apices Soluciones S.L.; Sistemas GenómicosCompleted
-
Danish Oncological Lung Cancer GroupTerminatedSmall Cell Lung Cancer | Extensive Disease | First-LineDenmark
-
University of LeedsUniversity College London Hospitals; The Leeds Teaching Hospitals NHS Trust; University... and other collaboratorsRecruitingNon Small Cell Lung CancerUnited Kingdom
-
Peking Union Medical College HospitalNot yet recruiting